haloperidol has been researched along with procyclidine in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (60.00) | 18.7374 |
1990's | 1 (4.00) | 18.2507 |
2000's | 4 (16.00) | 29.6817 |
2010's | 5 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cookson, IB; Owen, F; Ridges, AP | 1 |
Simpson, MA | 2 |
Barcs, G; Frecska, E; Goswami, U; Kassay-Farkas, A; Majláth, E; Perényi, A | 1 |
Brown, D; Cookson, J; Silverstone, T | 1 |
Anderer, P; Grünberger, J; Küfferle, B; Saletu, B | 1 |
Dinan, TG | 1 |
Kishnir, SL | 1 |
Kushnir, SL | 1 |
Gannon, P; Hsu, W; Itil, TM; Klingenberg, H | 1 |
Boissier, JR; Larousse, C; Simon, P; Villeneuve, A | 1 |
Holden, JM; Itil, TM; Keskiner, A; Patterson, CD | 1 |
Pethö, B; Ungvári, G | 1 |
Hermann, P; Presslich, O; Schanda, H | 1 |
Reid, AH | 1 |
Burke, M; King, DJ; Lucas, RA | 1 |
Baig, AM; Khan, NA; Kulsoom, H; Siddiqui, R | 1 |
1 review(s) available for haloperidol and procyclidine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for haloperidol and procyclidine
Article | Year |
---|---|
A pilot study of the role of prophylactic antiparkinson treatment during neuroleptic therapy.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Pilot Projects; Procyclidine; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia | 1989 |
Carbamazepine compared to haloperidol in acute mania.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Bipolar Disorder; Carbamazepine; Chlorpromazine; Female; Haloperidol; Humans; Leukocyte Count; Male; Middle Aged; Procyclidine; Psychiatric Status Rating Scales | 1989 |
Quantitative EEG, SPEM, and psychometric studies in schizophrenics before and during differential neuroleptic therapy.
Topics: Adult; Antipsychotic Agents; Attention; Brain; Dibenzazepines; Electroencephalography; Eye Movements; Haloperidol; Humans; Male; Memory; Procyclidine; Psychomotor Performance; Reaction Time; Schizophrenia | 1986 |
Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
Topics: Alpha Rhythm; Chronic Disease; Clinical Trials as Topic; Computers; Electroencephalography; Female; Fluphenazine; Haloperidol; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Placebos; Procyclidine; Psychiatric Status Rating Scales; Sleep; Thiothixene; Time Factors | 1974 |
20 other study(ies) available for haloperidol and procyclidine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Platelet monoamine oxidase activity during the course of a schizophreniform psychosis.
Topics: Blood Platelets; Cognition Disorders; Delusions; Emotions; Hallucinations; Haloperidol; Humans; Male; Middle Aged; Monoamine Oxidase; Procyclidine; Schizophrenia | 1975 |
Unrecognized drug-induced dystonias.
Topics: Adolescent; Basal Ganglia Diseases; Haloperidol; Humans; Male; Procyclidine | 1975 |
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Platelet Aggregation; Procyclidine; Schizophrenia; Sulpiride; Trifluoperazine | 1987 |
Hematemesis following discontinuation of psychoactive drugs in geriatric patients.
Topics: Aged; Chlorpromazine; Female; Haloperidol; Hematemesis; Humans; Imipramine; Male; Procyclidine; Psychotropic Drugs; Substance Withdrawal Syndrome | 1988 |
Tolerance of a high dose of haloperidol by an elderly patient.
Topics: Aged; Drug Tolerance; Haloperidol; Humans; Male; Procyclidine; Pyrrolidines; Schizophrenia, Paranoid | 1988 |
Digital computer analyzed sleep and resting EEG during haloperidol treatment.
Topics: Adult; Analysis of Variance; Animals; Arousal; Computers; Diagnosis, Computer-Assisted; Electroencephalography; Electromyography; Eye Movements; Female; Haloperidol; Heart Rate; Humans; Male; Procyclidine; Schizophrenia; Sleep; Sleep Stages; Sleep, REM | 1970 |
Flurothyl in mice: seizure, post-convulsive behavior, and interactions with psychotropic drugs.
Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Biperiden; Caffeine; Catalepsy; Central Nervous System Stimulants; Chlordiazepoxide; Chlorpromazine; Diazepam; Electroshock; Haloperidol; Humans; Imipramine; Iproniazid; Meprobamate; Monoamine Oxidase Inhibitors; Motor Activity; Parasympatholytics; Pargyline; Prenylamine; Procyclidine; Rats; Reflex; Reserpine; Seizures; Tranylcypromine | 1968 |
Letter: Delayed drug-induced dystonias.
Topics: Haloperidol; Humans; Male; Movement Disorders; Muscle Tonus; Muscular Diseases; Procyclidine; Time Factors | 1973 |
[Neuroleptic large dose therapy of schizophrenias].
Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Procyclidine; Schizophrenia; Schizophrenic Psychology | 1981 |
[Inpatient withdrawal treatment of heroin dependence with neuroleptics--an approach to addicts].
Topics: Administration, Oral; Adult; Antipsychotic Agents; Chlorprothixene; Drug Therapy, Combination; Female; Haloperidol; Heroin Dependence; Humans; Infusions, Parenteral; Male; Procyclidine; Promazine; Residential Treatment | 1983 |
Gilles de la Tourette syndrome in mental handicap.
Topics: Adult; Drug Therapy, Combination; Epilepsy, Tonic-Clonic; Female; Haloperidol; Humans; Intellectual Disability; Procyclidine; Psychotic Disorders; Tourette Syndrome | 1984 |
Antipsychotic drug-induced dysphoria.
Topics: Adult; Akathisia, Drug-Induced; Anti-Dyskinesia Agents; Antipsychotic Agents; Depressive Disorder; Female; Haloperidol; Humans; Male; Procyclidine | 1995 |
Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris.
Topics: Acanthamoeba castellanii; Amebiasis; Amebicides; Amiodarone; Amlodipine; Apomorphine; Balamuthia mandrillaris; Brain; Cells, Cultured; Digoxin; Drug Synergism; Drug Therapy, Combination; Encephalitis; Endothelial Cells; Haloperidol; Humans; Loperamide; Microvessels; Prochlorperazine; Procyclidine | 2014 |